About this trial
Every-day life means being part of a complex environment and performing complex tasks that usually involve a combination of motor and cognitive skills. However, the process of aging or the sequelae of neurological diseases such as atypical Parkinson's disease (APD) compromises motor-cognitive interaction necessary for an independent lifestyle. While motor-cognitive performance has been identified as an important goal for sustained health across different clinical populations, little is known about underlying brain function leading to these difficulties and how to best target these motor-cognitive difficulties in the context of rehabilitation and exercise interventions.
The challenge of improving treatments of motor-cognitive difficulties (such as dual-tasking and navigation) is daunting, and an important step is arriving at a method that accurately portrays these impairments in an ecologically valid state. The investigators aim therefore to explore brain function during complex walking in healthy and APD by investigating the effects of age and neurological disease on motor-cognitive performance and its neural correlates during three conditions of complex walking (dual-task walking, navigation and a combination of both) using non-invasive measures of brain activity (functional near infrared spectrometry, fNIRS) and advanced gait analysis in real time in older healthy adults and people with APD.
Eligibility criteria
Qualifiers
clinical diagnosis of PSP according to Movement Disorder Society (MDS) (2017) or
MSA according to MDS criteria (2022)
the ability to walk with or without a mobility device for ≤5 minutes continuously
Disqualifiers
cognitive difficulties affecting the ability to understand and/or follow verbal/written - instructions
severe freezing of gait
Severe hearing or visual impairments that affect participation in the assessments
Other neurological diseases
Trial design
Treatments tested in this trial
- Assessment of brain activity with fNIRS and behavioural assessments (motor, motor-cognitive and cognitive) during three complex walking conditions.
Treatment groups
Sponsors and collaborators
Karolinska Institutet
Lead sponsor
Karolinska University Hospital
Collaborator